Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 04, 2024 02:00 ET | Source: Verona Pharma plc Ohtuvayre™ (ensifentrine) launch…
OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis
OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase…
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Germantown, Maryland, and Venlo, the Netherlands, Nov. 04, 2024 (GLOBE NEWSWIRE) --…
Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
November 03, 2024 17:03 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia,…
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
November 03, 2024 16:00 ET | Source: Belite Bio, Inc SAN DIEGO,…
Walstreamz Set to Expand its E-commerce Solutions with the Launch of Ecom Private Label, eBay Automation, and TikTok Automation
PISCATAWAY, N.J., Nov. 02, 2024 (GLOBE NEWSWIRE) -- In the latest record,…
Fobi AI Responds To CTO (Cease Trade Order) Commitment To Financial Transparency and Audit Completion
November 01, 2024 19:41 ET | Source: Fobi AI Inc. VANCOUVER, BC,…
Legible Announces Appointment of Successor Auditor
November 01, 2024 18:00 ET | Source: Legible VANCOUVER, British Columbia, Nov.…
Intuitive Machines Announces Date for Third Quarter 2024 Financial Results Conference Call
HOUSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR,…
Nokia Corporation: Repurchase of own shares on 01.11.2024
Nokia CorporationStock Exchange Release1 November 2024 at 22:30 EET Nokia Corporation: Repurchase…
